Effect of health foods on cytochrome P450-mediated drug metabolism

[1]  S. Arora,et al.  In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data. , 2015, Toxicology letters.

[2]  R. V. van Breemen,et al.  High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions , 2015, Drug Metabolism and Disposition.

[3]  T. Kumagai,et al.  Development of a highly reproducible system to evaluate inhibition of cytochrome P450 3A4 activity by natural medicines. , 2015, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[4]  Xin He,et al.  Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine , 2015, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  William M. Lee,et al.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. , 2015, Gastroenterology.

[6]  Michael F. Santillo,et al.  Sex hormone modulation of both induction and inhibition of CYP1A by genistein in HepG2/C3A cells , 2015, In Vitro Cellular & Developmental Biology - Animal.

[7]  F. Ohtsu,et al.  The Current Status of Health Food- or Supplement-Related Adverse Health Effects , 2013 .

[8]  K. Yasuda,et al.  Metabolism of Sesamin by Cytochrome P450 in Human Liver Microsomes , 2010, Drug Metabolism and Disposition.

[9]  H. Takikawa,et al.  Drug‐induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006 , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  Caroline A. Lee,et al.  Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds. , 2008, Journal of pharmacological and toxicological methods.

[11]  M. Schwab,et al.  Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation , 2008, Analytical and bioanalytical chemistry.

[12]  Shiyong Chen,et al.  Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. , 2008, Biochemical pharmacology.

[13]  N. Vermeulen,et al.  Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. , 2007, Toxicology.

[14]  D. Greenblatt,et al.  Inhibition of human cytochromes P450 by components of Ginkgo biloba , 2004, The Journal of pharmacy and pharmacology.

[15]  T. Goosen,et al.  Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[16]  J. Pascussi,et al.  Expression of CYP3A4, CYP2B6, andCYP2C9 Is Regulated by the Vitamin D Receptor Pathway in Primary Human Hepatocytes* , 2002, The Journal of Biological Chemistry.

[17]  M. Harkey,et al.  Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life sciences.

[18]  M. Tohkin,et al.  A Questionnaire Survey of Health Food Utilization by Patients and Consumers Visiting Pharmacies and Assessment of Whether the Health Foods Noted in This Survey Inhibit CYP2D6 , 2014 .

[19]  S. Misaka,et al.  Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. , 2013, Drug metabolism and pharmacokinetics.

[20]  K. Yoshinari,et al.  Simultaneous expression of plural forms of human cytochrome P450 at desired ratios in HepG2 cells: adenovirus-mediated tool for cytochrome P450 reconstitution. , 2009, Drug metabolism and pharmacokinetics.

[21]  A. Kotani,et al.  Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. , 2004, Drug metabolism and pharmacokinetics.